SeD

Global BioLife initiates advanced research of a new universal therapeutic drug platform
Singapore eDevelopment Limited’s bio-medical subsidiary’s research into the Linebacker platform will be led by two-time Nobel Prize nominee Daryl Thompson.
US company to buy SeD’s IM subsidiary for US$700mil
US-based Fragmented Industry Exchange Inc (FIE) intends to acquire a wholly-owned instant messaging (IM) software subsidiary of Singapore eDevelopment Ltd (SeD) for US$700 million in shares and bonds, SeD has announced.
Subscribe to SNAP
Download Digerati50 2020-2021 PDF

Digerati50 2020-2021

Get and download a digital copy of Digerati50 2020-2021